Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

A small forehead lesion led to the discovery of a significant brain arteriovenous malformation in a young girl.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The yeast found in a sea lion's skin lesion was almost identical to that on healthy skin, suggesting environmental factors may affect fungal growth and the cause of the lesion is unclear.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Skin issues can indicate immune system problems.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Most pregnant women experience common skin changes like linea nigra and stretch marks.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.